About Pharmosa Biopharm
Pharmosa Biopharm is a company based in Taipei (Taiwan) founded in 2000.. Pharmosa Biopharm operates in a competitive market with competitors including Aerami, Beyond Air, Breath Therapeutics, Activaero and Pneuma Respiratory, among others.
- Headquarter Taipei, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Pharmosa Biopharm Inc.
-
Annual Revenue
$0 (USD)-46.72as on Dec 31, 2024
-
Net Profit
$0 (USD)-2070.83as on Dec 31, 2024
-
EBITDA
$0 (USD)-1040.44as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Pharmosa Biopharm
Pharmosa Biopharm is a publicly listed company on the TPEX with ticker symbol 6875 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Pharmosa Biopharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Pharmosa Biopharm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pharmosa Biopharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmosa Biopharm Comparisons
Competitors of Pharmosa Biopharm
Pharmosa Biopharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aerami, Beyond Air, Breath Therapeutics, Activaero and Pneuma Respiratory, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
|
|
| domain | founded_year | HQ Location |
Developer of device for treating respiratory conditions
|
|
| domain | founded_year | HQ Location |
Inhalation therapies are developed for severe respiratory orphan diseases.
|
|
| domain | founded_year | HQ Location |
Controlled breathing technologies for inhaler devices were developed.
|
|
| domain | founded_year | HQ Location |
Pulmonary drug delivery solutions are developed using AI-enabled inhalers.
|
|
| domain | founded_year | HQ Location |
Respiratory drug delivery devices are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmosa Biopharm
Frequently Asked Questions about Pharmosa Biopharm
When was Pharmosa Biopharm founded?
Pharmosa Biopharm was founded in 2000.
Where is Pharmosa Biopharm located?
Pharmosa Biopharm is headquartered in Taipei, Taiwan.
What does Pharmosa Biopharm do?
Pharmosa Biopharm was established in 2000 in Taipei, Taiwan, within the biopharmaceutical sector. Drug delivery systems are developed and supplied by the company, encompassing various formulations for pharmaceutical applications. Operations are centered on research, production, and distribution of these systems, serving clients in the healthcare industry across Taiwan and international markets. Focus is placed on innovative delivery technologies to support drug efficacy and stability.
Who are the top competitors of Pharmosa Biopharm?
Pharmosa Biopharm's top competitors include Beyond Air, Aerami and Breath Therapeutics.
Is Pharmosa Biopharm publicly traded?
Yes, Pharmosa Biopharm is publicly traded on TPEX under the ticker symbol 6875.
What is Pharmosa Biopharm's ticker symbol?
The ticker symbol of Pharmosa Biopharm is 6875 on TPEX.